Cargando…
Fingolimod modulates multiple neuroinflammatory markers in a mouse model of Alzheimer’s disease
Sphingosine 1-phosphate (SP1) receptors may be attractive targets for modulation of inflammatory processes in neurodegenerative diseases. Recently fingolimod, a functional S1P1 receptor antagonist, was introduced for treatment of multiple sclerosis. We postulated that anti-inflammatory mechanisms of...
Autores principales: | Aytan, Nurgul, Choi, Ji-Kyung, Carreras, Isabel, Brinkmann, Volker, Kowall, Neil W., Jenkins, Bruce G., Dedeoglu, Alpaslan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847010/ https://www.ncbi.nlm.nih.gov/pubmed/27117087 http://dx.doi.org/10.1038/srep24939 |
Ejemplares similares
-
Dual dose-dependent effects of fingolimod in a mouse model of Alzheimer’s disease
por: Carreras, Isabel, et al.
Publicado: (2019) -
Fingolimod effects on the brain are mediated through biochemical modulation of bioenergetics, autophagy, and neuroinflammatory networks
por: Mirzaei, Mehdi, et al.
Publicado: (2022) -
A Preliminary Study of Cu Exposure Effects upon Alzheimer’s Amyloid Pathology
por: Pilozzi, Alexander, et al.
Publicado: (2020) -
Microglial response to experimental periodontitis in a murine model of Alzheimer’s disease
por: Kantarci, Alpdogan, et al.
Publicado: (2020) -
Fingolimod modulates microglial activation to augment markers of remyelination
por: Jackson, Samuel J, et al.
Publicado: (2011)